Purchase Order 75N93025P00987
Award Date
5/14/25
Potential Completion Date
6/30/25
Potential Value
$16K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Biolegend, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $98,517.25 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other products supporting life science research and drug discovery. The contract, awarded on January 28, 2021, is for the procurement of COVID-19 research antibodies, with a period of performance through January 26, 2022....
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $8,377.50 to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the delivery of "Brilliant Violet Anti-Human Antibodies" to support the agency's research efforts. Biolegend, Inc. is a subsidiary of the parent company Revvity Inc. This contract...
This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Biolegend, Inc. for the supply of various biomedical research reagents and antibodies. The $3,088.75 contract supports research efforts across multiple federal agencies, particularly within the NIAID. Biolegend, a for-profit manufacturer of life science research products, has a history of providing specialized...
This federal contract award to Biolegend, Inc. is for the provision of multiple antibodies to support flow cytometry research. The $38,072.50 firm-fixed-price purchase order was awarded on January 12, 2016 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract does not have a set-aside designation. Biolegend is a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other...
This $5,373.75 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other life science research products. The contract is for the delivery of anti-mouse IgM reagents to support NIAID's research initiatives, which may include areas such as COVID-19, multiple sclerosis, and other...
This is a firm-fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc. The contract is for the delivery of various antibodies and related biomedical reagents to support research efforts. The contract has a ceiling value of $4,286.20 and an ultimate completion date of July 1, 2016. Biolegend, Inc. is a for-profit manufacturer and supplier of biomedical products, with...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
This is a $18,328.50 firm-fixed-price purchase order contract awarded to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of reagents and kits to support various research efforts across disease areas including COVID-19, multiple sclerosis, infectious diseases, allergies, immunology, oncology, and bone marrow disorders. Biolegend has a history of federal awards with the...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $22,041.90 purchase order to Biolegend, Inc., a medical division of Revvity Inc., for BIOLEGEND ANTIBODIES. The firm fixed price order runs from September 1, 2023 through October 31, 2023 for place of performance in San Diego, California. No major subcontractors or set aside designations were indicated. This small purchase supports the NIH/NIAID's research...